Israel Faces Early Flu Season Amid Vaccine Supply Delays

Israel is experiencing its first signs of a flu outbreak, with early cases and even fatalities reported. However, a significant delay in the arrival of flu vaccines at healthcare providers has caused concern among those accustomed to early immunization. The situation is compounded by the fact that the flu season appears to be starting earlier than anticipated.

Reports indicate that 47 people, including elderly individuals and staff, have contracted the flu at the "Beit BaLev" rehabilitation center in Kfar Saba, with three deaths attributed to the illness. While data from the Southern Hemisphere, particularly Australia, South Africa, and South America, often provides insights into the upcoming flu season in the Northern Hemisphere, experts caution that these predictions are not always precise due to potential virus mutations.

Despite the global recommendation to get vaccinated as early as possible, Israeli health maintenance organizations (HMOs) are facing vaccine shortages. Pharmaceutical companies delayed the release of vaccines due to the need to update strains, pushing back deliveries. While in previous years vaccines were available by early September, this year only a portion is expected in the coming days, with full supplies anticipated by mid-November. One HMO, Meuhedet, plans to prioritize larger clinics and areas with at-risk populations for the initial limited vaccine distribution, expecting mass vaccination to begin in mid-October.

Conversely, Clalit HMO anticipates that the phased vaccine delivery will not significantly impact its vaccination campaign, having already received its first batch and expecting the full order on time. The Ministry of Health stated that it has taken measures with HMOs and suppliers to expedite vaccine delivery, with hundreds of thousands of doses expected soon, even with a delay in WHO strain identification. Following quality control, these vaccines will be distributed to HMOs for public inoculation.

The article also emphasizes the seriousness of influenza, often underestimated as a mild illness, highlighting its potential for severe complications, hospitalization, and death, especially among the elderly, young children, and individuals with chronic conditions. It also touches upon the availability of vaccines for Respiratory Syncytial Virus (RSV) in infants and adults, noting the introduction of new mRNA-based flu vaccines in the US, which are not yet available in Israel.